Carney complex: Clinical and genetic 2010 update;Le complexe de Carney en 2010

Annales d'Endocrinologie

Volumn 71, Issue 6, 2010, Pages 486-493

  Vezzosi, D ^a,b   Vignaux, O ^b,c   Dupin, N ^b,c   Bertherat, J ^a,b,c  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Hôpital Cochin ^*  (France)

Author keywords

Cardiac myxoma; Carney complex; Cutaneous lentiginosis; Primary pigmented nodular adrenocortical disease; PRKAR1A gene mutation

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; DEXAMETHASONE; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADRENAL CORTEX; BREAST LESION; CARNEY COMPLEX; CHROMOSOME 17Q; CUSHING DISEASE; DISEASE ASSOCIATION; DRUG MEGADOSE; ENDOCRINE GLAND; GENE MUTATION; GENETIC DISORDER; GERM LINE; GONAD TUMOR; HEART MYXOMA; HUMAN; HYPOPHYSIS; HYPOPHYSIS TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; MYXOMATOSIS; NEURILEMOMA; NONHUMAN; OVARY TUMOR; RARE DISEASE; REVIEW; SKIN DEFECT; TESTIS TUMOR; THYROID GLAND; THYROID TUMOR;

BONE DISEASES; BREAST DISEASES; CARNEY COMPLEX; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; ENDOCRINE GLANDS; GONADS; HEART DISEASES; HUMANS; MYXOMA; PHOSPHORIC DIESTER HYDROLASES; SKIN DISEASES;

EID: 78651473464     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2010.08.002     Document Type: Review

References (56)

1. Carney J.A., Gordon H., Carpenter P.C., Shenoy B.V., Go V.L. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 1985, 64(4):270-283.
2. Bertherat J., Horvath A., Groussin L., Grabar S., Boikos S., Cazabat L., et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 2009, 94(6):2085-2091.
3. Stratakis C.A., Kirschner L.S., Carney J.A. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001, 86(9):4041-4046.
4. Kirschner L.S., Carney J.A., Pack S.D., Taymans S.E., Giatzakis C., Cho Y.S., et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000, 26(1):89-92.
5. Casey M., Vaughan C.J., He J., Hatcher C.J., Winter J.M., Weremowicz S., et al. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 2000, 106(5):R31-R38.
6. Tasken K., Skalhegg B.S., Tasken K.A., Solberg R., Knutsen H.K., Levy F.O., et al. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprotein Res 1997, 31:191-204.
7. Shabb J.B. Physiological substrates of cAMP-dependent protein kinase. Chem Rev 2001, 101(8):2381-2411.
8. Amieux P.S., Cummings D.E., Motamed K., Brandon E.P., Wailes L.A., Le K., et al. Compensatory regulation of RI-alpha protein levels in protein kinase A mutant mice. J Biol Chem 1997, 272(7):3993-3998.
9. Kirschner L.S., Sandrini F., Monbo J., Lin J.P., Carney J.A., Stratakis C.A. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000, 9(20):3037-3046.
10. Veugelers M., Wilkes D., Burton K., McDermott D.A., Song Y., Goldstein M.M., et al. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and PRKAR1A haploinsufficient mice. Proc National Acad Sci U S A 2004, 101(39):14222-14227.
11. Horvath A., Bossis I., Giatzakis C., Levine E., Weinberg F., Meoli E., et al. Large deletions of the PRKAR1A gene in Carney complex. Clin Cancer Res 2008, 14(2):388-395.
12. Groussin L., Kirschner L.S., Vincent-Dejean C., Perlemoine K., Jullian E., Delemer B., et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 2002, 71(6):1433-1442.
13. Groussin L., Horvath A., Jullian E., Boikos S., Rene-Corail F., Lefebvre H., et al. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 2006, 91(5):1943-1949.
14. Meoli E., Bossis I., Cazabat L., Mavrakis M., Horvath A., Stergiopoulos S., et al. Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. Cancer Res 2008, 68(9):3133-3141.
15. Pereira AM, Hes FJ, Horvath A, Woortman S, Greene E, Bimpaki E, et al. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families. Clin Endocrinol Metab 2010;95(1):338-42.
16. Amieux P.S., Howe D.G., Knickerbocker H., Lee D.C., Su T., Laszlo G.S., et al. Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. J Biol Chem 2002, 277(30):27294-27304.
17. Kirschner L.S., Kusewitt D.F., Matyakhina L., Towns W.H., Carney JA., Westphal H., et al. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 2005, 65(11):4506-4514.
18. Griffin K.J., Kirschner L.S., Matyakhina L., Stergiopoulos S., Robinson-White A., Lenherr S., et al. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors. Cancer Res 2004, 64(24):8811-8815.
19. Griffin K.J., Kirschner L.S., Matyakhina L., Stergiopoulos S.G., Robinson-White A., Lenherr S.M., et al. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet 2004, 41(12):923-931.
20. Sahut-Barnola I, de Joussineau C, Val P, Lambert-Langlais S, Damon C, Lefrancois-Martinez AM, et al. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific PRKAR1A knockout mice. PLoS Genet 2010 Jun 10;6(6) (in press).
21. Robinson-White A., Hundley T.R., Shiferaw M., Bertherat J., Sandrini F., Stratakis C.A. Protein kinase A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 2003, 12(13):1475-1484.
22. Matyakhina L., Pack S., Kirschner L.S., Pak E., Mannan P., Jaikumar J., et al. Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 2003, 40(4):268-277.
23. Stratakis C.A., Carney J.A., Lin J.P., Papanicolaou D.A., Karl M., Kastner D.L., et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996, 97(3):699-705.
24. Horvath A., Boikos S., Giatzakis C., Robinson-White A., Groussin L., Griffin K.J., et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 2006, 38(7):794-800.
25. Horvath A., Giatzakis C., Robinson-White A., Boikos S., Levine E., Griffin K., et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 2006, 66(24):11571-11575.
26. Horvath A., Mericq V., Stratakis C.A. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 2008, 358(7):750-752.
27. Horvath A., Giatzakis C., Tsang K., Greene E., Osorio P., Boikos S., et al. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Europ J Hum Genet 2008, 16(10):1245-1253.
28. Libe R., Fratticci A., Coste J., Tissier F., Horvath A., Ragazzon B., et al. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res 2008, 14(12):4016-4024.
29. Shenoy B.V., Carpenter P.C., Carney J.A. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol 1984, 8(5):335-344.
30. Groussin L., Jullian E., Perlemoine K., Louvel A., Leheup B., Luton J.P., et al. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 2002, 87(9):4324-4329.
31. Stratakis C.A., Sarlis N., Kirschner L.S., Carney J.A., Doppman J.L., Nieman L.K., et al. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 1999, 131(8):585-591.
32. Gunther D.F., Bourdeau I., Matyakhina L., Cassarino D., Kleiner D.E., Griffin K., et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?. J Clin Endocrinol Metab 2004, 89(7):3173-3182.
33. Courcoutsakis N, Prassopoulos P, Stratakis CA. CT findings of primary-pigmented nodular adrenocortical disease: rare cause of ACTH-independent Cushing syndrome. AJR 2010;194(6):W541.
34. Pack S.D., Kirschner L.S., Pak E., Zhuang Z., Carney J.A., Stratakis C.A. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the " complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). J Clin Endocrinol Metab 2000, 85(10):3860-3865.
35. Boikos S.A., Stratakis C.A. Pituitary pathology in patients with Carney complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary 2006, 9(3):203-209.
36. Stergiopoulos S.G., Abu-Asab M.S., Tsokos M., Stratakis C.A. Pituitary pathology in Carney complex patients. Pituitary 2004, 7(2):73-82.
37. Stratakis C.A., Courcoutsakis N.A., Abati A., Filie A., Doppman J.L., Carney J.A., et al. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 1997, 82(7):2037-2043.
38. Stratakis C.A., Papageorgiou T., Premkumar A., Pack S., Kirschner L.S., Taymans S.E., et al. Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. J Clin Endocrinol Metab 2000, 85(11):4359-4366.
39. Premkumar A., Stratakis C.A., Shawker T.H., Papanicolaou D.A., Chrousos G.P. Testicular ultrasound in Carney complex: report of three cases. J Clin Ultrasound 1997, 25(4):211-214.
40. Chang B., Borer J.G., Tan P.E., Diamond D.A. Large-cell calcifying Sertoli cell tumor of the testis: case report and review of the literature. Urology 1998, 52(3):520-522. [discussion 22-3].
41. Brown B., Ram A., Clayton P., Humphrey G. Conservative management of bilateral Sertoli cell tumors of the testicle in association with the Carney complex: a case report. J Pediatr Surg 2007, 42(9):E13-E15.
42. Lytras A., Tolis G. Reproductive disturbances in multiple neuroendocrine tumor syndromes. Endocr Relat cancer 2009, 16(4):1125-1138.
43. Burton K.A., McDermott D.A., Wilkes D., Poulsen M.N., Nolan M.A., Goldstein M., et al. Haploinsufficiency at the protein kinase A RI-alpha gene locus leads to fertility defects in male mice and men. Mol Endocrinol (Baltimore) 2006, 20(10):2504-2513.
44. Wieacker P., Stratakis C.A., Horvath A., Klose S., Nickel I., Buhtz P., et al. Male infertility as a component of Carney complex. Andrologia 2007, 39(5):196-197.
45. Young W.F., Carney J.A., Musa B.U., Wulffraat N.M., Lens J.W., Drexhage H.A. Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50years later. N Engl J Med 1989, 321(24):1659-1664.
46. Mateus C., Palangie A., Franck N., Groussin L., Bertagna X., Avril M.F., et al. Heterogeneity of skin manifestations in patients with Carney complex. J Am Acad Dermatol 2008, 59(5):801-810.
47. Abdel-Malek Z.A. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 2001, 58(3):434-441.
48. Butler A.A., Cone R.D. The melanocortin receptors: lessons from knockout models. Neuropeptides 2002, 36(2-3):77-84.
49. Gantz I., Fong T.M. The melanocortin system. Am J Physiol 2003, 284(3):E468-E474.
50. Carney J.A., Toorkey B.C. Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am J Surg Pathol 1991, 15(8):722-731.
51. Carney J.A., Toorkey B.C. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol 1991, 15(8):713-721.
52. Carney J.A., Boccon-Gibod L., Jarka D.E., Tanaka Y., Swee R.G., Unni K.K., et al. Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am J Surg Pathol 2001, 25(2):164-176.
53. Gennari M., Stratakis C.A., Hovarth A., Pirazzoli P., Cicognani A. A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations. Clin Endocrinol (Oxf) 2008, 69(5):751-755.
54. Pery C., Avallone S., Regenet N., Coron E., Le Borgne J. Intraductal papillary mucinous tumor of the pancreas in 2 twin brothers diagnosed as having the Carney complex. Pancreas 2009, 38(2):237-239.
55. Ryou K.S., Lee S.H., Park S.H., Park J., Hwang S.K., Hamm I.S. Multiple fusiform myxomatous cerebral aneurysms in a patient with Carney complex. J Neurosurg 2008, 109(2):318-320.
56. Horvath A., Bertherat J., Groussin L., Guillaud-Bataille M., Tsang K., Cazabat L., et al. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat 2008, 31(4):369-379.